title: The Middle East respiratory syndrome--how worried should we be?
abstract: Ten years after the severe acute respiratory syndrome epidemic, a second coronavirus, the Middle East respiratory syndrome coronavirus (MERS-CoV), has been identified as the cause of a highly lethal pneumonia in patients in the Middle East and in travelers from this region. Over the past 9 months, since the virus was first isolated, much has been learned about the biology of the virus. It is now clear that MERS-CoV is transmissible from person to person, and its close relationship with several bat coronaviruses suggests that these animals may be the ultimate source of the infection. However, many key issues need to be addressed, including identification of the proximate, presumably zoonotic, source of the infection, the prevalence of the infection in human populations, details regarding clinical and pathological features of the human infection, the establishment of a small rodent model for the infection, and the virological and immune basis for the severe disease observed in most patients. Most importantly, we do not know whether a MERS-CoV epidemic is likely or not. Infection with the virus has so far resulted in only 91 cases and 46 deaths (as of 29 July 2013), but it is nonetheless setting off alarm bells among public health officials, including Margaret Chan, Director-General of the World Health Organization, who called MERS-CoV "a threat to the entire world." This article reviews some of the progress that has been made and discusses some of the questions that need to be answered.
authors: Department of Microbiology, University of Iowa, Iowa City, Iowa, USA. Stanley-perlman@uiowa.edu
authors: Stanley
authors: S
authors: Perlman
mesh_terms: D000818:Animals; D017934:Coronavirus / Q000302:isolation & purification* / Q000472:pathogenicity; D018352:Coronavirus Infections / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology / Q000821:virology; D004196:Disease Outbreaks; D006801:Humans; D008877:Middle East / Q000453:epidemiology; D011024:Pneumonia, Viral / Q000453:epidemiology / Q000401:mortality / Q000473:pathology / Q000821:virology; D015995:Prevalence; D015047:Zoonoses / Q000453:epidemiology / Q000401:mortality / Q000473:pathology / Q000821:virology
references: J Virol. 2007 Feb;81(3):1162-73
references: 17108019
references: PLoS Pathog. 2010 May 06;6(5):e1000896
references: 20463816
references: N Engl J Med. 2012 Nov 8;367(19):1814-20
references: 23075143
references: Nature. 2013 Mar 14;495(7440):251-4
references: 23486063
references: J Virol. 2007 Jan;81(2):813-21
references: 17079315
references: N Engl J Med. 2013 Aug 1;369(5):407-16
references: 23782161
references: J Virol. 2013 May;87(9):5300-4
references: 23449793
references: J Immunol. 2002 Feb 1;168(3):1028-35
references: 11801635
references: J Virol. 2013 May;87(10):5502-11
references: 23468491
references: J Virol. 2005 Dec;79(23):14909-22
references: 16282490
references: Lancet Infect Dis. 2013 Oct;13(10):859-66
references: 23933067
references: Science. 2004 Mar 12;303(5664):1666-9
references: 14752165
references: J Immunol. 2013 Jun 15;190(12):6468-77
references: 23677473
references: Lancet. 2013 Aug 24;382(9893):694-9
references: 23831141
references: Emerg Infect Dis. 2007 Sep;13(9):1340-7
references: 18252105
references: J Virol. 2013 Jun;87(12):6604-14
references: 23552422
references: N Engl J Med. 2013 Apr 18;368(16):1560-2
references: 23550601
references: Virus Res. 2008 Apr;133(1):113-21
references: 18045721
references: mBio. 2012 Nov 20;3(6):
references: 23170002
references: mBio. 2012 Dec 11;3(6):
references: 23232719
references: Circ J. 2010 Mar;74(3):405-10
references: 20134095
references: MMWR Morb Mortal Wkly Rep. 2013 Jun 14;62(23):480-3
references: 23760190
references: Virology. 2001 Oct 25;289(2):230-8
references: 11689046
references: Crit Rev Clin Lab Sci. 2003 Jun;40(3):209-94
references: 12892317